Skip to content
Home/Companies/MedTech/Prostatype Genomics
Prostatype Genomics

Prostatype Genomics

MedTech·Sweden·Exited 2020·Held 7yr
Entry
2013
Hold
7yr
Exit
2020

Who owns Prostatype Genomics?

Prostatype Genomics is a Swedish MedTech company, formerly owned by Creathor Ventures, exited in 2020 (exit via IPO). No current private equity owner is on file.

Hand-verified · updated 2026-07-07

Open JSON · CC-BY
Creathor Ventures
Investor
Creathor Ventures
Creathor Venture Fund III · 2012 · VC

Key facts

HQSweden
SectorMedTech
StatusAcquired
Websiteprostatype.com
Exit Type
IPO
Exit Year
2020

More from Creathor Venture Fund III

Other portfolio companies in the same fund.

Allthings Technologies
Allthings Technologies
Active
SaaSSwitzerland· 2017
Blueprint Genetics
Exited 2020
MedTechFinland· 2017
to Quest Diagnostics
EchoRing (R3 Communications)
EchoRing (R3 Communications)
Active
Deep TechGermany· 2017
Humanoo
Exited 2024
HealthTechGermany· 2017
to TELUS Health
CryoTherapeutics
CryoTherapeutics
Active
MedTechBelgium· 2016
COBI
Exited 2017
MobilityGermany· 2015
to Bosch eBike Systems

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Prostatype Genomics?

Prostatype Genomics was formerly owned by Creathor Ventures, exited in 2020. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue